The objective of the current study was to elucidate the within-host dynamics of bovine viral diarrhea virus (BVDV) type-1 infection to better understand how this virus could be maintained in white-tailed deer (Odocoileus virginianus, WTD) populations. The BVDV type-1 used in this study was originally isolated from a free-ranging WTD in Indiana. Four fawns were intranasally inoculated with 2 ml BVDV type-1 strain 544 WTD at a 10 6 tissue culture infectious dose (TCID 50 )/ml. Two fawns were inoculated with sham inoculum (negative controls). Animals were bled on days 27, 0, 1, 7, and 14 postinoculation (PID) for a complete blood count, chemistry panel, buffy coat (BC), real-time RT-PCR, and virus neutralization (VN). On days 7 and 14 PID, nasal and rectal swabs were obtained for RT-PCR and two of the virus-inoculated fawns and one of the negative controls fawns were euthanized. At necropsy, multiple samples were obtained for histopathology and in situ hybridization (ISH). Quantitative RT-PCR was performed on serum, BC, nasal, and rectal swabs. All animals tested negative for BVDV type 1 neutralizing antibodies on day 0 and animals in the control group remained seronegative throughout the study. No gross lesions were observed at necropsy. BVDV was isolated from lung and pooled lymph nodes from all BVDV-inoculated fawns on days 7 and 14 PID. Infected deer had lymphoid depletion, apoptosis, and lymphoid necrosis in the Peyer's patches and mesenteric lymph nodes. BVDV was detected in lymphoid tissues of infected animals by ISH. No lesions or virus were identified in control fawns. On day 7 PID, samples from two virus-inoculated fawns were positive for BVDV by virus isolation and RT-PCR from BC and nasal swab samples. One fawn was also positive on a rectal swab. Nasal and rectal swabs from all animals were negative on day 14. Results indicate that infection of WTD with BVDV is possible, and leads to histologic lesions in variety of tissues. In addition, virus shedding into the environment through feces and other secretions is likely.
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is a positive-stranded RNA pestivirus (Bolin and Grooms, 2004) and has been associated with vast economic losses to the dairy cattle industry (Chi et al., 2002; Houe, 2003; Tiwari et al., 2005) . The combined economic impact of BVDV has been estimated at a 20 to 57 million dollar loss per million calving in the US. Based on the 2005 USA calf crop of 38 million, the cost of BVDV to USA producers was 760 million to 2.2 billion dollars in that year (Driskell and Ridpath, 2006) .
In cattle, the virus causes a variety of clinical manifestations which can vary from clinically inapparent infection to acute or chronic severe disease (Baker, 1995) ; BVDV has been associated with neonatal diarrhea in calves (Werdin et al., 1989) and might predispose them to respiratory tract infections (Brodersen and Kelling, 1998) . However, the most important economical consequence of BVDV infection is reproductive loss. Depending on the time of infection during gestation, BVDV can cause early embryonic death, abortion, congenital defects, and variety of postnatal clinical manifestations including fever, nasal and ocular mucopurulent discharge, profuse watery diarrhea, and mucosal lesions (Grooms, 2004) . Fetuses that survive infection with noncytopathic BVDV between 18 and 125 days of gestation invariably develop immune tolerance to the virus and subsequently become persistently infected (PI; Grooms, 2004) . Because PI calves are thought to be the primary nidus of viral infection within herds, the key for BVDV control is to interfere with the process by which the PI calves are generated (Lindberg and Houe, 2005) .
Although many US Department of Agriculture (USDA)-approved BVDV vaccines (using killed or modified-live virus) are commercially available, the efficacy of these vaccines to protect fetuses against infection has been questioned (Dubovi, 1992; Van Campen et al., 1998; van Oirrschot et al., 1999) . Sporadic occurrence of PI calves from vaccinated cows is consistent with the results of experimental challenge-exposure studies. Those studies have demonstrated partial protection against fetal infection using both modified-live and inactivated BVDV vaccines (Ellsworth et al., 1993) . Furthermore, a retrospective study in the northwestern US found an increased prevalence of fetal infections and consequently PIs between 1980 and 2000, despite a high (60%) rate of vaccination (Evermann and Ridpath, 2002) . This might suggest that the use of BVDV vaccines does not sufficiently reduce the incidence of BVDV fetal infections. Purchasing PI heifers is a primary source of BVDV introduction into naïve herds (Houe, 2005) ; hence BVDV introduction into herds continues despite vaccination.
Over-pasture fence contact and other animal traffic were also identified as important risk factors for BVDV introduction into noninfected herds (Valle et al., 1999) . Direct or indirect contact of infected animals or populations, wild or domestic, with susceptible populations at the interface of their ranges is an important factor responsible for the cause of outbreaks of diseases (Bengis et al., 2002) . Furthermore, many pathogens that can influence domestic animal health are sustained in wildlife populations (Van Campen et al., 2001) . Hence, the impact of a disease in wild animal populations can have economic significance if the wild animal species is a reservoir of infection for domestic animals.
The evidence for BVDV infection in free-ranging animals includes serologic surveys and virus isolations (Nettelton, 1990) . Serologic surveys in free-ranging and captive wildlife indicate infection with BVDV or related pestiviruses in a variety of species such as Scottish red deer (Cervus elaphus scoticus), Roe deer (Capreolus capreolus), European Bison (Bison bonasus) and other wild ruminants (Romvary, 1965; McMartin et al., 1977; Doyle and Heuschele, 1983; Nielsen et al., 2000; Borchers et al., 2002) . Thus, BVDV infection introduction into the herd through wildlife is plausible.
Wildlife reservoirs for domestic livestock diseases can seriously undermine the effectiveness of disease control strategy in domestic species by escalating the number of susceptible animals in which the disease can persist, especially at the wildlifelivestock interface. As suggested by Simpson (2002) , the reintroduction of BVDV to negative cattle herds can be due to contact with a wildlife reservoir.
The objective of the current study was to elucidate the within-host dynamics of BVDV infection and to relate it to how the virus can be maintained in white-tailed deer (WTD, Odocoileus virginianus) populations, using a BVDV type-1 isolated from a free-ranging WTD in Indiana. Specifically, we aimed to assess if inoculation with BVDV can cause WTD to develop typical clinical and pathologic signs as described for cattle, as well if they shed the virus through feces and other secretions. A better understanding of the potential risk of interspecies BVDV transmission between free-ranging WTD and domestic cattle may lead to improvement of BVDV biosecurity and control programs.
MATERIAL AND METHODS

Inoculum and study animals
In November 2006, 311 ear notches and more than 434 lymph nodes were collected from harvested deer during the firearm hunting seasons in Indiana, USA and tested by capture ELISA, virus isolation, and PCR assays for BVDV. Noncytopathic BVDV isolates from two deer were genotyped as a BVDV type-1a and one of these isolates was used in this study as inoculum (GenBank accession number 1077526; Pogranichniy et al., 2008) .
Six WTD fawns from a captive deer breeding farm in northern Indiana were used in this study. Fawns were between 2 to 3 wk old and were negative for BVDV virus by quantitative RT-PCR assay on buffy coat (BC) samples. Neutralizing antibodies against BVDV were not detected in any of these animals. All fawns were housed in separate rooms in a biosecurity facility for animal experiments at Purdue University. Fawns were housed in the facility 3 days before the beginning of the trial and were bottle fed with a deer milk replacer (Zoologic Doe Milk Replacer, PetAg, Hampshire, Illinois, USA) 4-5 times a day throughout both the acclimatization (3 days) and the trial (14 days) period.
Experimental infection and sample collection
Four fawns were intranasally inoculated with 2 ml of noncytopathic BVDV 1 strain 544 WTD virus suspension with a titer of 10 6 tissue culture infectious dose (TCID 50 )/ml; the inoculum had been passed three times in cell culture free of pestiviruses. Two fawns received sham inoculums (medium only) and served as negative controls.
The clinical condition of each animal was evaluated daily; rectal temperature, pulse, and respiration rates were recorded. Clinical evaluations of attitude, appetite, consistency of feces, and presence or absence of abnormal respiratory signs also were recorded daily.
Animals were bled on days 27 (on farm), 0 (immediately prior to inoculation), and 1, 7, and 14 postinoculation (PID). Whole blood and serum were collected for complete blood count (CBC), chemistry panel, BC real-time RT-PCR on BC, virus neutralization (VN), and ELISA. On days 7 and 14 PID, two of the virus-inoculated fawns and one of the negative controls fawns were euthanized for postmortem examination using intravenous euthanasia solution (Fatal-PlusH, Vortech Pharmaceuticals, Dearborn, Michigan, USA) according to label directions. On both days nasal and rectal swabs were obtained for real-time RT-PCR.
At necropsy, samples of lymphoid organs (tonsil, spleen, thymus, and retropharyngeal, mandibular, and mesenteric lymph nodes), digestive tract (esophagus, rumen, abomasum, duodenum, jejunum, colon, Peyer's patches in the jejunum, ileum, colon, and rectum), respiratory tract (trachea and lung), urogenital organs (kidney and testes), CNS tissues (cerebrum, hippocampus, and cerebellum), heart, skin, and bone marrow were collected for histopathology, virus isolation, and realtime RT-PCR; serum was collected for virus neutralization assays for BVDV antibodies. From each tissue, one sample was fixed in 10% formalin for histopathology and the second sample was frozen at 280 C for virus isolation and real-time RT-PCR. Serum samples were stored at 220 C. The CBC was performed by the Clinical Pathology Laboratory of Purdue Veterinary Teaching Hospital.
Virus isolation and PCR
Madin Darby Bovine Kidney (MDBK) cells were prepared in 48-well plates grown in media supplemented with 5% (v/v) horse serum (Sigma Chemical Co., St. Louis, Missouri, USA), 20 mM L-glutamine (Gibco/BRL Life Science, Grand Island, New York, USA), and an antibiotic-antimycotic mixture that consists of 100 IU/ml penicillin, 10 mg/ml streptomycin, and 50 mg/ml gentamicin (Sigma Chemical Co.). The samples were inoculated (0.25 ml/well) in duplicate or triplicate on cell suspension and left for 24 hr before being removed. Inoculated cells were observed daily for cytopathic effect (CPE). When CPE was evident in more than 70% of the cell monolayer, cell culture medium was harvested and inoculated onto freshly prepared cells in duplicate. At day 2 postinoculation, cells on duplicate 48-well plates were fixed after the cell culture media was harvested by immersing them in cold 80% aqueous acetone and subjected to immunofluorescence microscopy using FITC-labeled antibodies (USDA NVSL, Ames, Iowa, USA; American Bioresearch, Inc., Seymour, Tennessee, USA) raised against BVDV. The BVDV virus for inoculum was propagated using same protocol only in 75 cm 2 cell culture flasks. Quantitative real-time reverse transcriptase (RT)-PCR was performed on serum, BC, nasal, and rectal swabs as previously described (Baxi et al., 2006) . Viral RNA was extracted from the appropriate sample using QIAampH viral RNA extraction kit (Qiagen, Santa Clarita, California, USA) as recommended by the manufacturer. Real-time PCR was performed on clinical samples as described by targeting 59 untranslated region of the viral genome. Real-time RT-PCR was used with the QuantiTect Probe real-time RT-PCR Kit (Qiagen) in a 25 ml reaction volume using 2.5 ml extracted template. Primers were added at a final concentration of 0.4 mM each, and the probe was at a final concentration of 0.2 mM. For quantification, we used a set of BVDV type 1 preparations each with a known virus titer to generate a standard curve. The set of standards was included in each run with clinical samples to determine the validity, relative amount, and reproducibility of the assay. The amount of BVDV in each sample was calculated by converting Ct value to virus titer using the standard curve.
Histopathology and in-situ hybridization (ISH)
Collected tissues were fixed by immersion in 10% neutral buffered formalin immediately after collection. Fixed tissues were processed, embedded, and sectioned at 5 mm using routine technique. Each section was then stained with hematoxylin and eosin.
In order to demonstrate BVDV nucleic acid, ISH was performed on sections of small intestine and mesenteric lymph node of BVDV-inoculated and of negative control deer using a specific 20-mer oligoprobe designed to hybridize with the gene of the viral nonstructural protein 3 (NS3) with sequence information (59 TAG ATG AA(G)T ACC ACT GTG C-39). Briefly, tissue sections from inoculated and control animals were deparaffinized, digested with 20 mg/ml of proteinase K, and prehybridized at 42 C for 1 hr. Hybridization was performed overnight at 42 C with the specific 59-end digoxigenin labeled oligoprobe at a concentration of 2 ng/ml. The detection system consisted of antidigoxigenin antibody conjugated with alkaline phosphatase (dilution 1:500) and the substrates nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Roche Diagnostics Corporation, Indianapolis, Indiana, USA). Sections of intestine and ear notch of acutely and persistently BVDV infected calves, respectively, were used as positive controls. This procedure was modified from a previously published protocol (Gregory et al., 1996) .
Virus neutralization
Test sera were diluted in a two-fold series from an initial dilution of 1:4 to a maximum dilution of 1:512; each dilution was added to wells of a 96-well tissue culture plate in triplicate. Antigen consisting of 50 ml of media containing 200 TCID of BVDV type 1 and BVDV type 2 was added to each well and plates were incubated at 37 C for 2 hr. Fifty ml of suspension of MDBK cells at 3 3 10 5 cells/ml were added to each well and the plates were incubated for a further 3 days at 37 C at 5% CO 2 . Antibody titers were determined by microscopic examination of the monolayer of cells for cytopathic effect 72 hr postinoculation. Results were expressed as the reciprocal of the serum dilution at which 50% neutralization of virus will occur. A 2-fold or greater antibody titer increase was considered as seroconversion.
RESULTS
Fawns from both groups remained healthy throughout the study. Temperature, pulse, and respiration remained in the same range before and after inoculation, and appetite remained good during the postinoculation period. Sporadically, before and during the study period, all fawns had fresh blood in their feces, but not for more than three consecutive days. Vital signs, level of activity, and appetite were not affected. Examination of the feces of one of the fawns demonstrated the presence of Eimeria oocysts and Strongyloides papillosus ova. As a result, all animals were treated with 50 mg/kg amprolium (CoridH, Merial US, Duluth, Georgia, USA) once a day for five consecutive days at the first sign of hematochezia.
All animals tested negative for BVDV type 1 neutralizing antibodies prior to inoculation and throughout the entire study period.
On day 7 PID, BC and nasal swab samples from two BVDV-inoculated fawns were positive using real-time RT-PCR. One of these two fawns also had a positive rectal swab on day 7 PID. On day 14 PID, all nasal and rectal swabs as well as BC samples obtained from the remaining two virus-inoculated fawns and one shaminoculated negative control fawn were negative for BVDV (Table 1) . BVDV was isolated from lung and pooled lymph nodes of all four BVDV-inoculated fawns following necropsy (Table 1) .
Gross lesions were not identified in any of the fawns. On day 7 PID, BVDVinfected deer had mild to slight lymphoid depletion with apoptosis and lymphoid necrosis in the Peyer's patches and mesenteric lymph nodes (Figs. 1 and 2) . By day 14 PID, a profound lymphoid depletion was identified. Mild lymphocytic vasculitis with some smooth muscle cell degeneration and necrosis was present in a few small-caliber muscular arteries in the bone marrow, pancreas, kidney, small intestine, and large intestine.
Negative control sections remained negative for BVDV (Fig. 3A) . Among the virus-inoculated fawns necropsied at day 7 and 14 PID, positive signal for BVDV was present within lymphocytes in lymphoid aggregates in the Payer's patches (Fig. 3B) , mesenteric lymph nodes, and in scattered ganglion cells of the myentric plexi in the small intestine (Table 1) .
DISCUSSION
This study confirmed that WTD fawns could be experimentally infected with a type-1 BVDV isolated from free-roaming deer in northern Indiana, develop histologic lesions, and shed the virus through feces and nasal secretions. Recently, Ridpath et al. (2007) described a similar study where fawns were inoculated with BVDV isolated from free-living WTD. Unlike Ridpath et al. (2007) , however, clinical signs were not observed in this study, despite successful infection. The differences between the two studies likely are due to the use of different BVDV isolates or infectious dose. Van Campen et al. (1997) describes a similar study in mule deer (Odocoileus hemionus) and WTD inoculated with the NewYork-1 strain of BVDV isolated from cattle. Similar to our study, none of the animals in the Van Campen study developed clinical signs, although virus was recovered as long as days 15 PID. The absence of clinical signs increases the probability that BVDV infection in WTD would not incapacitate the deer, which increases the chance that WTD can remain in contact with cattle and serve as a reservoir of the virus for cattle. Potential transmission through virus shedding by persistently infected (PI) animals within a cattle herd is well documented (Grooms, 2004) . Epidemiologically, the role of persistently infected WTD in BVDV transmission to herdmates should be further investigated. To study PI in deer, Passler et al. (2007) infected pregnant WTD does (at 50 days gestation) with BVDV which originated from cattle, and one doe delivered a PI fawn and a mummified fetus.
The potential role of both PI WTD and transiently infected deer on the control of BVDV in domestic cattle is not currently understood. Our study indicates that BVDV type 1 isolated from deer was infectious to fawns and caused lesions. Thus, BVDV feasibly could be shed into the environment. Data from this experiment indicates that horizontal transmission of BVDV between individual deer might be plausible, and based on our results, infections in a white-tailed deer herd can occur without overt clinical signs. Because deer are often abundant near cattle farms (Raizman et al., 2005) , future studies should address the feasibility of horizontal transmission between deer and cattle and vice versa through direct and indirect contact.
